Amplia Therapeutics Ltd (ATX) - Total Liabilities

Latest as of March 2026: AU$1.97 Million AUD ≈ $1.39 Million USD

Based on the latest financial reports, Amplia Therapeutics Ltd (ATX) has total liabilities worth AU$1.97 Million AUD (≈ $1.39 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Amplia Therapeutics Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Amplia Therapeutics Ltd - Total Liabilities Trend (2010–2026)

This chart illustrates how Amplia Therapeutics Ltd's total liabilities have evolved over time, based on quarterly financial data.

Amplia Therapeutics Ltd Competitors by Total Liabilities

The table below lists competitors of Amplia Therapeutics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Wisekey International Holding AG SW:WIHN	Switzerland	CHF53.44 Million
Pangaea Oncology S.A. MC:PANG	Spain	€8.43 Million
Budi Starch & Sweetener Tbk JK:BUDI	Indonesia	Rp2.33 Trillion
Univastu India Limited NSE:UNIVASTU	India	Rs2.18 Billion
1895 of Wisconsin Inc Bancorp NASDAQ:BCOW	USA	$525.62 Million
UY Scuti Acquisition Corp. NASDAQ:UYSC	USA	$58.23 Million
Bridgford Foods Corporation NASDAQ:BRID	USA	$35.56 Million
LondonMetric Property Plc LSE:LMP	UK	GBX3.25 Billion

Liability Composition Analysis (2010–2026)

This chart breaks down Amplia Therapeutics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Amplia Therapeutics Ltd (ATX) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	19.78	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amplia Therapeutics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amplia Therapeutics Ltd (2010–2026)

The table below shows the annual total liabilities of Amplia Therapeutics Ltd from 2010 to 2026.

Year	Total Liabilities	Change
2026-03-31	AU$1.97 Million ≈ $1.39 Million	+2.95%
2025-03-31	AU$1.91 Million ≈ $1.35 Million	-44.20%
2024-03-31	AU$3.43 Million ≈ $2.42 Million	+20.29%
2023-03-31	AU$2.85 Million ≈ $2.02 Million	+8.07%
2022-03-31	AU$2.64 Million ≈ $1.87 Million	+388.95%
2021-03-31	AU$539.13K ≈ $381.47K	+5.58%
2020-03-31	AU$510.62K ≈ $361.30K	-3.08%
2019-03-31	AU$526.86K ≈ $372.79K	+88.55%
2018-03-31	AU$279.42K ≈ $197.71K	-69.22%
2017-03-31	AU$907.87K ≈ $642.38K	-11.97%
2016-03-31	AU$1.03 Million ≈ $729.75K	+127.72%
2015-03-31	AU$452.90K ≈ $320.45K	+12.18%
2014-03-31	AU$403.73K ≈ $285.67K	+111.38%
2013-03-31	AU$191.00K ≈ $135.14K	-92.51%
2012-03-31	AU$2.55 Million ≈ $1.80 Million	+43.32%
2011-03-31	AU$1.78 Million ≈ $1.26 Million	-20.18%
2010-03-31	AU$2.23 Million ≈ $1.58 Million	--

About Amplia Therapeutics Ltd

AU:ATX Australia Biotechnology

Market Cap

$56.30 Million

AU$79.56 Million AUD

Market Cap Rank

#21425 Global

#737 in Australia

Share Price

AU$0.16

Change (1 day)

+14.81%

52-Week Range

AU$0.11 - AU$0.27

All Time High

AU$16.20